Safety and Immunogenicity of Sars-cov-2 Vaccine in Patients With Rheumatic Diseases
NCT05191368
·
clinicaltrials.gov ↗
UNKNOWN
Status
500
Enrollment
OTHER
Sponsor class
Conditions
Rheumatic Disease
Interventions
OTHER:
No intervention
Sponsor
Yunnan University of Chinese Medicine